Somatic IL4R mutations in primary mediastinal large B-cell lymphoma lead to constitutive JAK-STAT signaling activation.

Blood
Elena ViganòChristian Steidl

Abstract

Primary mediastinal large B-cell lymphoma (PMBCL) is a distinct subtype of diffuse large B-cell lymphoma thought to arise from thymic medullary B cells. Gene mutations underlying the molecular pathogenesis of the disease are incompletely characterized. Here, we describe novel somatic IL4R mutations in 15 of 62 primary cases of PMBCL (24.2%) and in all PMBCL-derived cell lines tested. The majority of mutations (11/21; 52%) were hotspot single nucleotide variants in exon 8, leading to an I242N amino acid change in the transmembrane domain. Functional analyses establish this mutation as gain of function leading to constitutive activation of the JAK-STAT pathway and upregulation of downstream cytokine expression profiles and B cell-specific antigens. Moreover, expression of I242N mutant IL4R in a mouse xenotransplantation model conferred growth advantage in vivo. The pattern of concurrent mutations within the JAK-STAT signaling pathway suggests additive/synergistic effects of these gene mutations contributing to lymphomagenesis. Our data establish IL4R mutations as novel driver alterations and provide a strong preclinical rationale for therapeutic targeting of JAK-STAT signaling in PMBCL.

References

Mar 26, 1999·European Journal of Immunology·T JungC H Heusser
May 26, 1999·International Archives of Allergy and Immunology·T JungC Neumann
Jul 13, 2002·International Journal of Cancer. Journal International Du Cancer·Ewerton M MaggioSibrand Poppema
Mar 27, 2004·Blood·Chrystelle GuiterFlavia Castellano
May 18, 2004·Trends in Immunology·Giuseppina Bonizzi, Michael Karin
Oct 7, 2004·Trends in Molecular Medicine·Talal A Chatila
Jan 24, 2007·Genes, Chromosomes & Cancer·Marc A WenigerThomas F E Barth
Oct 5, 2007·Leukemia·B HerrerosM A Piris
May 3, 2008·Leukemia & Lymphoma·José RodríguezMiguel Piris
Jan 13, 2009·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Cecile MeierAlexandar Tzankov
Apr 22, 2009·The Journal of Experimental Medicine·Roland SchmitzRalf Küppers
Sep 2, 2010·Clinical Immunology : the Official Journal of the Clinical Immunology Society·Marcia A ChanLanny J Rosenwasser
Dec 16, 2010·Cancer Cell·Lixin RuiLouis M Staudt
Dec 17, 2010·The Journal of Immunology : Official Journal of the American Association of Immunologists·Qyana K GriffithLisa M Ganley-Leal
Jun 28, 2011·Blood·Christian Steidl, Randy D Gascoyne
Jul 29, 2011·Nature·Ryan D MorinMarco A Marra
Sep 6, 2011·Nature Genetics·Priscila P ZenattiJoão T Barata
Feb 7, 2012·Molecular Cell·Xueliang GaoZhi-Ren Liu
Jul 31, 2012·Nature Genetics·Michael KrauthammerRuth Halaban
Aug 7, 2013·Nature Genetics·Veronique FrattiniAntonio Iavarone
Jan 7, 2014·Cell Reports·Laura PasqualucciRiccardo Dalla-Favera
Jul 11, 2014·Nature Reviews. Cancer·David W Scott, Randy D Gascoyne
Jun 8, 2015·Current Opinion in Hematology·Anja Mottok, Christian Steidl
Aug 27, 2015·Journal of Cell Science·Kristina KurgonaiteChristian Bökel

❮ Previous
Next ❯

Citations

Dec 13, 2018·The American Journal of Surgical Pathology·Clémentine SarkozyAlexandra Traverse-Glehen
Feb 12, 2019·British Journal of Haematology·Charlotte LeesJay Gunawardana
Jan 15, 2020·Cold Spring Harbor Perspectives in Medicine·Nathanael G Bailey, Kojo S J Elenitoba-Johnson
Nov 19, 2019·Pathology·Narittee SukswaiL Jeffrey Medeiros
Sep 23, 2020·Blood·Clémentine SarkozyChristian Steidl
Mar 9, 2021·Blood·Gerben DunsChristian Steidl
Jul 9, 2021·Expert Review of Anticancer Therapy·Vincent CamusClémentine Sarkozy

❮ Previous
Next ❯

Related Concepts

Related Feeds

B-Cell Lymphoma

B-cell lymphomas include lymphomas that affect B cells. This subtype of cancer accounts for over 80% of non-Hodgkin lymphomas in the US. Here is the latest research.